Copenhagen, 06 Nov 2002
Meeting of the COST JAF Group will take place in the following three parts:
Part I:
10h00: Biomaterials
Chair: Prof. Luc Balant
1. Introduction and adoption of the agenda
2. Adoption of the minutes of the previous meeting
3. "Biomaterials in the general, vascular and heart surgery in the limelight of long-term clinical follow up " (Ferenc Jacab)
4. "Interdisciplinary biomat centres: difficulties and synergies between four different faculties, including the Faculty of Medicine, and the cooperation with industry" (Hartwig Höcker)
5. Ethical issues in "biomaterials" (Knut W. Ruyter)
6. News from the relevant COST Technical Committees
7. Proposals for new COST Actions related to biomaterials
8. Strategies for biomaterials research in the Framework Programmes of the European Commission (Gianpietro van de Goor)
9. General discussion in the light of the CSO mandate (doc. COST 312/2/01 REV 2)
10. Any other items with regard to biomaterials
Part II
14h00: SIG
Chair: Prof. John Bartzis, Vice-Chair, CSO
11. Outcome of the Chemistry Workshop (presentation by the TC Chemistry Chairman)
12. Outcome of the NANOSTAG brainstorm meeting (presentation by the TC NANOSTAG Chairman)
13. International Cooperation (Proposal from the Greek delegation, doc. COST 240/02 Annex 2)
14. Issues related to the CSO - TC Chairs meeting on 2 December
15. TC Evaluation/Restructuring (doc. COST 267/02)
16. Any other items of strategic interest
Part III:
The meeting will continue on Tuesday, 19 November, at 10h00 09h00
Chair: Eva M. KLAPER, Vice-Chair, CSO
17. COST Action Statistics
18. Budget: status and budget allocation 2003 and indicative planning up to 2006 (duration of FP6)
19. Creation of 5th COST Fund: volume – exchange of opinions
20. Voting rules: exchange of opinions
21. Reimbursement of TC delegates: preparation of general decision and practicalities
22. Any other business
Danish Presidency Website http://www.eu2002.dk/main/